Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» At $475,000, new cancer drug raises thorny questions about drug pricing — and value
At $475,000, new cancer drug raises thorny questions about drug pricing — and value
At $475,000, new cancer drug raises thorny questions about drug pricing — and value
Submitted by
admin
on September 4, 2017 - 10:11am
Source:
Stat
News Tags:
drug pricing
CAR-T
Novartis
Kymriah
Headline:
At $475,000, new cancer drug raises thorny questions about drug pricing — and value
Do Not Allow Advertisers to Use My Personal information
